LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (NASDAQ:RGDX) today announced that its president and CEO, Kathleen Danenberg, will provide a business overview, including an update on its ResponseDXTM PCR-based genetic tests, at the Collins Stewart Fourth Annual Growth Conference at the Mandarin Oriental Hotel in New York City on July 8-10. Danenberg will present July 9 at 9 a.m. ET.
